Cellbyte vs Zocdoc

Side-by-side comparison of AI visibility scores, market position, and capabilities

Zocdoc leads in AI visibility (86 vs 40)
Cellbyte logo

Cellbyte

EmergingHealthcare

General

AI pharma drug launch platform compressing market access research from months to minutes; six-figure ARR within weeks of launch with Bayer as client across 12 markets.

AI VisibilityBeta
Overall Score
C40
Category Rank
#382 of 596
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
46
Perplexity
36
Gemini
37

About

Cellbyte is an AI-powered pharmaceutical drug launch platform that accelerates global drug launches by providing real-time pricing and market access intelligence — compressing processes that traditionally take months or years (reference pricing analysis, health technology assessment research, payer landscape mapping) into minutes using AI-driven data aggregation and analysis. Founded in 2024 and a Y Combinator graduate, Cellbyte raised $2.75 million in seed funding led by Frontline Ventures and Y Combinator, achieving six-figure ARR within weeks of launch.\n\nCellbyte's platform aggregates regulatory approval data, drug pricing reference lists, payer coverage policies, and health technology assessment outcomes across multiple countries to help pharmaceutical market access teams make faster, better-informed launch sequence decisions. Global drug launches require navigating distinct pricing and reimbursement systems in each country — reference pricing (where one country's price affects another's) makes launch sequencing strategically critical and data-intensive. Cellbyte automates the research that market access consultants previously performed manually.\n\nIn 2025, Cellbyte secured major clients including Bayer across 12 live markets — demonstrating enterprise adoption velocity unusual for a seed-stage company. The pharmaceutical market access software market includes specialized players like IQVIA (market data), ZS Associates (consulting), and early-stage AI entrants. The total addressable market is substantial given the global pharmaceutical market's hundreds of billions in annual drug launches. Cellbyte's 2025-2026 strategy focuses on expanding the breadth of markets covered (targeting all major pharma markets globally), deepening AI capabilities for predictive pricing modeling, and growing its pharmaceutical client base beyond the initial anchor customers.

Full profile
Zocdoc logo

Zocdoc

GrowthHealthTech

Patient Scheduling Marketplace

Zocdoc is a patient appointment booking marketplace that lets patients find and book in-network doctors in real time, with insurance verification and same-day availability filters.

AI VisibilityBeta
Overall Score
A86
Category Rank
#11 of 596
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
80
Gemini
92

About

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Patients can filter by specialty, insurance plan, location, and next available appointment, then book online in seconds — eliminating the phone-tag and hold-time historically required to schedule care. The platform verifies insurance acceptance in real time and sends automated reminders to reduce no-shows.

Full profile

AI Visibility Head-to-Head

40
Overall Score
86
#382
Category Rank
#11
76
AI Consensus
70
stable
Trend
stable
46
ChatGPT
88
36
Perplexity
80
37
Gemini
92
41
Claude
92
40
Grok
86

Key Details

Category
General
Patient Scheduling Marketplace
Tier
Emerging
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Zocdoc
Patient Scheduling Marketplace

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.